Schedule 33B Transitional Provision in relation to the Windsor FrameworkF1
- 1Existing marketing authorisations
- 2Existing applications for marketing authorisation
- 3Post-authorisation processes
Annotations
Textual amendments
- F1
Sch. 33B inserted (1.1.2025) by The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 146